Cyclerion Therapeutics Secures Funding and Expands CNS Focus

TipRanksDec 17 08:48 ET

Cyclerion Therapeutics Advances Growth Strategy With Key License Amendments and Asset Evaluations

Quiver QuantitativeDec 17 08:12 ET

Cyclerion Leverages SGC Stimulator Portfolio To Drive Growth With $1.75M Upfront Payments, Renegotiated Agreements For Praliciguat And Olinciguat, And Strategic Focus On CNS Pipeline Expansion

BenzingaDec 17 08:10 ET

Cyclerion's SGC Stimulator Portfolio Generates Revenues to Enable Company Growth

GlobeNewswireDec 17 08:08 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaDec 5 16:05 ET

Express News | Cyclerion Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS"

BenzingaDec 5 13:03 ET